From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Research marks one of the longest gene therapy study follow-ups to date PHILADELPHIA, April 17, 2025 /PRNewswire/ -- Researchers at Children's Hospital of Philadelphia (CHOP) in collaboration with ...

Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...

Since its inception in 1994, Born Free/New Beginnings, a program of Catholic Charities, has served as a visible sign of Christ’s love for pregnant and parenting mothers in Mississippi.

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

Reducing steroid exposure as soon as inflammation is adequately controlled may be a viable option for certain patients with KD.

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in RA.

Three new gaming carts donated to Perth Children’s Hospital will now bring a welcome distraction to sick kids at their ...